ALAN W DUNTON
CIK 1304773 · Chief Exec Officer & President · last filed 2026-01-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$914.1K
Companies
6
Total Filings
118
Lifetime Open-Market Net
$3.59M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CRMD | Director | 70,703 | $8.74 | $617.9K | -$338.3K | 16 | 2026-01-27 |
| OGEN | Director | 25,623 | $0.62 | $15.9K | -$186.7K | 28 | 2025-12-15 |
| PTN | Director | 20,601 | $13.61 | $280.3K | $4.02M | 32 | 2025-12-11 |
| MNOV | Director | — | $1.23 | — | $0 | 4 | 2010-06-15 |
| PANACOS PHARMACEUTICALS, INC. (PANC) Delisted | Chief Exec Officer & President | 240,865 | — | — | $96.3K | 8 | 2008-05-05 |
| Adams Respiratory Therapeutics, Inc. (ARXT) Delisted | Director | 0 | — | — | $0 | 7 | 2008-01-30 |
Recent Filings · Page 3 of 12
118 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-08-02 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | PTN | Grant (A) | +73,000 | $0 | EDGAR |
| 2022-02-23 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2021-12-17 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2021-07-02 | PTN | Buy (P) | +20,000 | $12.3K | EDGAR |
| 2021-07-01 | PTN | Grant (A) | +20,000 | $12.3K | EDGAR |
| 2021-06-24 | PTN | Grant (A) | +77,000 | $0 | EDGAR |
| 2021-02-19 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2021-01-13 | CRMD | Grant (A) | — | $0 | EDGAR |
| 2020-08-14 | CRMD | Buy (P) | +5,000 | $19.8K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.